Research: Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
16 Mar, 2018 | 02:14h | UTCCommentaries: Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial – TCTMD (free) AND CARES: Increased Risk of Death With Febuxostat in Patients With Gout and CV Disease – American College of Cardiology (free) AND